BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kosmider S, Lipton L. Adjuvant therapies for colorectal cancer. World J Gastroenterol 2007; 13(28): 3799-3805 [PMID: 17657833 DOI: 10.3748/wjg.v13.i28.3799]
URL: https://www.wjgnet.com/1007-9327/full/v13/i28/3799.htm
Number Citing Articles
1
Kuan-Yin Lin, Shiow-Ching Shun, Yeur-Hur Lai, Jin-Tung Liang, Jau-Yih Tsauo. Comparison of the Effects of a Supervised Exercise Program and Usual Care in Patients With Colorectal Cancer Undergoing ChemotherapyCancer Nursing 2014; 37(2): E21 doi: 10.1097/NCC.0b013e3182791097
2
Manuel Campos de Gouveia, Laura Elisabete Ribeiro Barbosa. Timing of neoadjuvant therapy and surgical treatment in rectal cancerJournal of Coloproctology 2019; 39(02): 178 doi: 10.1016/j.jcol.2018.11.003
3
P. N. Siriwardana, A. Pathmeswaran, J. Hewavisenthi, K. I. Deen. Histopathology reporting in colorectal cancer: a proforma improves qualityColorectal Disease 2009; 11(8): 849 doi: 10.1111/j.1463-1318.2008.01680.x
4
Winnie Lai Ting Kan, Chun Yin, Hong Xi Xu, Gang Xu, Kenneth Kin Wah To, Chi Hin Cho, John Anthony Rudd, Ge Lin. Antitumor effects of novel compound, guttiferone K, on colon cancer by p21Waf1/Cip1‐mediated G0/G1 cell cycle arrest and apoptosisInternational Journal of Cancer 2013; 132(3): 707 doi: 10.1002/ijc.27694
5
Katarzyna Wrzeszcz, Piotr Rhone, Katarzyna Kwiatkowska, Barbara Ruszkowska-Ciastek. Hypercoagulability State Combined with Post-Treatment Hypofibrinolysis in Invasive Breast Cancer: A Seven-Year Follow-Up Evaluating Disease-Free and Overall SurvivalLife 2023; 13(5): 1106 doi: 10.3390/life13051106
6
Satya Narayan, Srinivasa Ramisetti, Aruna S. Jaiswal, Brian K. Law, Ashona Singh-Pillay, Parvesh Singh, Shantu Amin, Arun K. Sharma. ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cellsEuropean Journal of Medicinal Chemistry 2019; 161: 456 doi: 10.1016/j.ejmech.2018.10.052
7
Lingyu Li, Wei Li, Chang Wang, Xu Yan, Yizhuo Wang, Chao Niu, Xiaoying Zhang, Min Li, Huimin Tian, Cheng Yao, Haofan Jin, Fujun Han, Dongsheng Xu, Wei Han, Dan Li, Jiuwei Cui. Adoptive transfer of natural killer cells in combination with chemotherapy improves outcomes of patients with locally advanced colon carcinomaCytotherapy 2018; 20(1): 134 doi: 10.1016/j.jcyt.2017.09.009
8
Da Kang, Shanshan Huang, Yijun Liao, Siyuan Mi, Jingying Zhou, Yu Feng, Riming Huang, Zhen-hai Lu, Z. Z. Pan, Wenjuan Ma, Gong Chen, Jia-Xing Yue, Jingxiu Huang, R. X. Zhang. Vasorin (VASN) overexpression promotes pulmonary metastasis and resistance to adjuvant chemotherapy in patients with locally advanced rectal cancerJournal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05473-4
9
Yinan Bao, Si Chen, Ruxin Jiang, Yuewei Li, Lei Chen, Feng Li, Jiandong Tai. The physical activity of colorectal cancer survivors during chemotherapySupportive Care in Cancer 2020; 28(2): 819 doi: 10.1007/s00520-019-04873-3
10
Jae Myeong Lee, Hee Cheol Kim, In Ja Park, Dae Dong Kim, Chang Sik Yu, Jin Cheon Kim. The Characteristics of Colorectal Cancer in Patients Older than 80 YearsJournal of the Korean Society of Coloproctology 2007; 23(6): 490 doi: 10.3393/jksc.2007.23.6.490
11
Stefano Fogli, Michele Caraglia. Genotype-based therapeutic approach for colorectal cancer: state of the art and future perspectivesExpert Opinion on Pharmacotherapy 2009; 10(7): 1095 doi: 10.1517/14656560902889775
12
Yan Zhang, Junli Ma, Sai Zhang, Ganlu Deng, Xiaoling Wu, Jingxuan He, Haiping Pei, Hong Shen, Shan Zeng. A prognostic analysis of 895 cases of stage III colon cancer in different colon subsitesInternational Journal of Colorectal Disease 2015; 30(9): 1173 doi: 10.1007/s00384-015-2273-z
13
Satya Narayan, Aruna S. Jaiswal, Ritika Sharma, Akbar Nawab, Lizette Vila Duckworth, Brian K. Law, Maria Zajac-Kaye, Thomas J. George, Jay Sharma, Arun K. Sharma, Robert A. Hromas. NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populationsOncotarget 2017; 8(34): 57246 doi: 10.18632/oncotarget.19778
14
Zhao Gao, Shi-Kai Wu, Shi-Jie Zhang, Xin Wang, Ying-Chao Wu, Xuan Jin. Adjuvant chemotherapy for isolated resectable colorectal lung metastasis: A retrospective study using inverse probability treatment weighting propensity analysisWorld Journal of Gastrointestinal Surgery 2024; 16(10): 3171-3184 doi: 10.4240/wjgs.v16.i10.3171
15
Pirita Varpe, Heikki Huhtinen, Arto Rantala, Juha Grönroos. Patient’s age should not play a key role in clinical decisions on surgical treatment of rectal cancerAging Clinical and Experimental Research 2010; 22(1): 42 doi: 10.1007/BF03324814
16
Yoshiko Inafuku, Tomohisa Furuhata, Makoto Tayama, Kenji Okita, Toshihiko Nishidate, Toru Mizuguchi, Yasutoshi Kimura, Koichi Hirata. Matrix metalloproteinase‐2 expression in stromal tissues is a consistent prognostic factor in stage II colon cancerCancer Science 2009; 100(5): 852 doi: 10.1111/j.1349-7006.2009.01116.x
17
Jens Neumann, David Horst, Lydia Kriegl, Susanne Maatz, Jutta Engel, Andreas Jung, Thomas Kirchner. A simple immunohistochemical algorithm predicts the risk of distant metastases in right‐sided colon cancerHistopathology 2012; 60(3): 416 doi: 10.1111/j.1365-2559.2011.04126.x
18
Shanthi Sabarimurugan, Chellan Kumarasamy, Madhav Madurantakam Royam, Karthik Lakhotiya, Gothandam Kodiveri Muthukaliannan, Suja Ramalingam, Rama Jayaraj. Validation of miRNA prognostic significance in stage II colorectal cancerMedicine 2019; 98(12): e14570 doi: 10.1097/MD.0000000000014570
19
Hiba Al Naji, Jean M Winter, Susanne K Pedersen, Amitesh Roy, Susan E Byrne, Graeme P Young, Erin L Symonds. Evaluating the Role of Methylated Circulating Tumor DNA in Combination With Pathological Prognostic Factors for Predicting Recurrence of Colorectal CancerBiomarker Insights 2024; 19 doi: 10.1177/11772719241232870
20
Takatoshi Matsuyama, Toshiaki Ishikawa, Kaoru Mogushi, Tsuyoshi Yoshida, Satoru Iida, Hiroyuki Uetake, Hiroshi Mizushima, Hiroshi Tanaka, Kenichi Sugihara. MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancerInternational Journal of Cancer 2010; 127(10): 2292 doi: 10.1002/ijc.25256
21
C.L. Ringland, H.-T. Arkenau, D.L. O'Connell, R.L. Ward. Second primary colorectal cancers (SPCRCs): experiences from a large Australian Cancer RegistryAnnals of Oncology 2010; 21(1): 92 doi: 10.1093/annonc/mdp288
22
Chi-Jung Huang, Shung-Haur Yang, Chia-Long Lee, Yu-Che Cheng, Szu-Yun Tai, Chih-Cheng Chien, Syed A. Aziz. Ribosomal Protein S27-Like in Colorectal Cancer: A Candidate for Predicting PrognosesPLoS ONE 2013; 8(6): e67043 doi: 10.1371/journal.pone.0067043
23
Satya Narayan, Ritika Sharma. Molecular mechanism of adenomatous polyposis coli-induced blockade of base excision repair pathway in colorectal carcinogenesisLife Sciences 2015; 139: 145 doi: 10.1016/j.lfs.2015.08.019
24
QIANG ZHANG, JIE YANG, QUN QIAN. Evidence-based treatment of patients with rectal cancerOncology Letters 2016; 11(3): 1631 doi: 10.3892/ol.2016.4100